Choose content
Displaying 85 to 96 of 554 results
Generic justification
¹⁷⁷Lutetium PSMA radioligand therapy for the treatment of metastatic castrate-resistant prostate cancer: Evidence synthesis to support a generic justification decision
FoilsitheProtocol for a health technology assessment of extending BowelScreen to those aged 50 to 54 years
Foilsithe- Annual report
2023 Health Technology Assessment Directorate Knowledge Sharing and Impact Assessment report
Foilsithe Assessment Generic justification
Magnetic resonance imaging-guided radiotherapy: Protocol for an evidence review to inform generic justification
Foilsithe